Clayface Box Office Opens Solid as Holmes Doc Surges

The Clayface box office race is officially on, and it is shaping up as one of the weirder weekends of the fall. Warner Bros. and DC Studios opened its R-rated body-horror movie in North America on Friday, October 23, after Thursday previews landed right where industry watchers expected.

According to Deadline, the film pulled in an estimated three and a half million dollars from previews that began at two in the afternoon. That is a solid number for a movie about a Batman villain most casual fans could not pick out of a lineup.

What the previews tell us

Deadline's weekend forecast sits between twenty and twenty-five million dollars domestically. Variety, meanwhile, reports that some projections run higher, with studio-side hopes reaching toward the thirty-million range, and a global debut somewhere around forty-five to fifty-five million once overseas is counted.

Context matters here. Deadline points out that the preview figure beats Kraven the Hunter, which opened to a dismal eleven million dollars, and sits not far from Birds of Prey. Next to horror, it is close to Other Mommy and ahead of Smile from 2022.

The film also cost only forty-four million dollars to make before marketing, according to Deadline, and it was shot in the United Kingdom. Compared with the giant budgets behind recent DC tentpoles, that makes profit a much easier target.

The story behind the movie

Clayface is directed by James Watkins and stars Tom Rhys Harries as Matt Hagen, a baby-faced Hollywood actor whose career stalls and whose face is destroyed after a run-in with the wrong people. It is a stand-alone story rather than a chapter in a shared universe, and the screenplay comes from Mike Flanagan.

Reception is helping. Deadline notes a seventy-six percent critics score on Rotten Tomatoes and strong marks from the opening-night crowd, including four and a half stars on PostTrak. Variety frames it as a cheap, R-rated swing from producers Peter Safran and James Gunn.

A documentary is the real plot twist

The unexpected rival is not another superhero. It is You Can See Everything, an A24 documentary from Nathan Fielder and Lance Oppenheim about Theranos founder Elizabeth Holmes. Deadline says it wrapped its first week with about twenty-five and a half million dollars and won several weekdays at the box office.

That is wild for a film that runs close to three hours. It opened on only eight hundred fifty-five screens, and it expands to roughly twenty-six hundred locations this weekend, which could give it room to challenge Clayface for the top spot. The pitch to Gen Z is simple: scammer-core is a genre now.

Other openers worth a look

The weekend is crowded. The Olivia Colman drama Wicker opened with a strong specialty start of six hundred twenty thousand dollars in previews, while Taika Waititi's take on Klara and the Sun launched in limited release. Laika's stop-motion film Wildwood is also rolling out.

Deadline adds that a win for Clayface would give the newly combined Paramount and Warner Bros. its second straight number-one opener, after Street Fighter. You can follow more movie coverage on our movies page.

How the numbers compare

Opening-weekend math is rarely simple, and this one has several moving parts. Previews only capture the most eager fans, usually people who show up on a Thursday afternoon, so analysts treat them as a rough signal instead of a promise. A strong Friday and a healthy Saturday would show that general audiences are following the superfans.

The Hollywood Reporter notes that the studio has projected an opening between twenty-five and thirty million dollars domestically, plus another twenty to twenty-five million overseas, according to The Hollywood Reporter. That range is wider than Deadline's, which shows how uncertain the weekend still is.

A final Clayface box office tally near the top of those ranges would make the film a cheap success, and anything near the bottom would still cover its production budget over time through international sales and home viewing. That safety net is exactly why studios like these smaller, scarier bets.

Gen Z audiences are the wild card. Younger moviegoers have turned documentaries, horror and midnight-style weirdness into group-chat events, and both of this weekend's leaders fit that mold. Word of mouth on social feeds could matter more than any trailer.

What to watch next

The real answer arrives Sunday, when actual weekend totals replace forecasts. Front-loading is the risk for any fan-driven horror release, so the second-day drop will say more than previews did.

For now, the early signs are good for DC's low-budget experiment. Whether a body-horror villain can beat a Theranos documentary is a sentence nobody expected to write this year, and it makes this weekend worth tracking.